172 related articles for article (PubMed ID: 38133141)
21. Dysregulation of Multiple Signaling Neurodevelopmental Pathways during Embryogenesis: A Possible Cause of Autism Spectrum Disorder.
Upadhyay J; Patra J; Tiwari N; Salankar N; Ansari MN; Ahmad W
Cells; 2021 Apr; 10(4):. PubMed ID: 33924211
[TBL] [Abstract][Full Text] [Related]
22. Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.
D'Aguanno S; Valentini E; Tupone MG; Desideri M; Di Martile M; Spagnuolo M; Buglioni S; Ercolani C; Falcone I; De Dominici M; Milella M; Rizzo MG; Calabretta B; Cota C; Anichini A; Trisciuoglio D; Del Bufalo D
J Exp Clin Cancer Res; 2018 Nov; 37(1):278. PubMed ID: 30454024
[TBL] [Abstract][Full Text] [Related]
23. Cellular and molecular characterization of multiplex autism in human induced pluripotent stem cell-derived neurons.
Lewis EMA; Meganathan K; Baldridge D; Gontarz P; Zhang B; Bonni A; Constantino JN; Kroll KL
Mol Autism; 2019; 10():51. PubMed ID: 31893020
[TBL] [Abstract][Full Text] [Related]
24. Secreted semaphorin 5A activates immune effector cells and is a biomarker for rheumatoid arthritis.
Gras C; Eiz-Vesper B; Jaimes Y; Immenschuh S; Jacobs R; Witte T; Blasczyk R; Figueiredo C
Arthritis Rheumatol; 2014 Jun; 66(6):1461-71. PubMed ID: 24585544
[TBL] [Abstract][Full Text] [Related]
25. The association of GPR85 with PSD-95-neuroligin complex and autism spectrum disorder: a molecular analysis.
Fujita-Jimbo E; Tanabe Y; Yu Z; Kojima K; Mori M; Li H; Iwamoto S; Yamagata T; Momoi MY; Momoi T
Mol Autism; 2015; 6():17. PubMed ID: 25780553
[TBL] [Abstract][Full Text] [Related]
26. Implication of Endoplasmic Reticulum Stress in Autism Spectrum Disorder.
Kawada K; Mimori S
Neurochem Res; 2018 Jan; 43(1):147-152. PubMed ID: 28770435
[TBL] [Abstract][Full Text] [Related]
27. Autism Spectrum Disorder: Signaling Pathways and Prospective Therapeutic Targets.
Baranova J; Dragunas G; Botellho MCS; Ayub ALP; Bueno-Alves R; Alencar RR; Papaiz DD; Sogayar MC; Ulrich H; Correa RG
Cell Mol Neurobiol; 2021 May; 41(4):619-649. PubMed ID: 32468442
[TBL] [Abstract][Full Text] [Related]
28. Semaphorin 3A influences neuronal processes that are altered in patients with autism spectrum disorder: Potential diagnostic and therapeutic implications.
Matrone C; Ferretti G
Neurosci Biobehav Rev; 2023 Oct; 153():105338. PubMed ID: 37524141
[TBL] [Abstract][Full Text] [Related]
29. Autism Spectrum Disorder/Intellectual Disability-Associated Mutations in Trio Disrupt Neuroligin 1-Mediated Synaptogenesis.
Tian C; Paskus JD; Fingleton E; Roche KW; Herring BE
J Neurosci; 2021 Sep; 41(37):7768-7778. PubMed ID: 34353896
[TBL] [Abstract][Full Text] [Related]
30. Neuropsychopathology of Autism Spectrum Disorder: Complex Interplay of Genetic, Epigenetic, and Environmental Factors.
Bhandari R; Paliwal JK; Kuhad A
Adv Neurobiol; 2020; 24():97-141. PubMed ID: 32006358
[TBL] [Abstract][Full Text] [Related]
31. Semaphorin 5A is a bifunctional axon guidance cue for axial motoneurons in vivo.
Hilario JD; Rodino-Klapac LR; Wang C; Beattie CE
Dev Biol; 2009 Feb; 326(1):190-200. PubMed ID: 19059233
[TBL] [Abstract][Full Text] [Related]
32. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
Ko PH; Lenka G; Chen YA; Chuang EY; Tsai MH; Sher YP; Lai LC
Int J Oncol; 2020 Jan; 56(1):165-177. PubMed ID: 31789397
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological inhibition of the primary endocannabinoid producing enzyme, DGL-α, induces autism spectrum disorder-like and co-morbid phenotypes in adult C57BL/J mice.
Fyke W; Alarcon JM; Velinov M; Chadman KK
Autism Res; 2021 Jul; 14(7):1375-1389. PubMed ID: 33886158
[TBL] [Abstract][Full Text] [Related]
34. Invariant Sema5A inhibition serves an ensheathing function during optic nerve development.
Oster SF; Bodeker MO; He F; Sretavan DW
Development; 2003 Feb; 130(4):775-84. PubMed ID: 12506007
[TBL] [Abstract][Full Text] [Related]
35. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
Smith IN; Thacker S; Jaini R; Eng C
J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
[TBL] [Abstract][Full Text] [Related]
36. Extracellular domain of semaphorin 5A serves a tumor‑suppressing role by activating interferon signaling pathways in lung adenocarcinoma cells.
Chen MZ; Su LY; Ko PH; Hsu MH; Chuang LL; Chen LH; Lu TP; Chuang EY; Chow LP; Tsai MH; Hsu HH; Lai LC
Int J Oncol; 2022 Feb; 60(2):. PubMed ID: 35059729
[TBL] [Abstract][Full Text] [Related]
37. Impaired neurodevelopmental pathways in autism spectrum disorder: a review of signaling mechanisms and crosstalk.
Kumar S; Reynolds K; Ji Y; Gu R; Rai S; Zhou CJ
J Neurodev Disord; 2019 Jun; 11(1):10. PubMed ID: 31202261
[TBL] [Abstract][Full Text] [Related]
38. Screening for modulators of autism spectrum disorder using induced human neurons.
Rao SR; Kostic A; Baillargeon P; Fernandez-Vega V; de Anda MR; Fletcher K; Shumate J; Scampavia L; Buxbaum JD; Spicer TP
SLAS Discov; 2022 Mar; 27(2):128-139. PubMed ID: 35123134
[TBL] [Abstract][Full Text] [Related]
39. JNK phosphorylation of paxillin, acting through the Rac1 and Cdc42 signaling cascade, mediates neurite extension in N1E-115 cells.
Yamauchi J; Miyamoto Y; Sanbe A; Tanoue A
Exp Cell Res; 2006 Sep; 312(15):2954-61. PubMed ID: 16814769
[TBL] [Abstract][Full Text] [Related]
40. Autism spectrum disorder-associated genes and the development of dentate granule cells.
Ito H; Morishita R; Nagata KI
Med Mol Morphol; 2017 Sep; 50(3):123-129. PubMed ID: 28534217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
